{ "name": "Compounded Tirzepatide Provider Reputation Index 2026", "url": "https://rxcomparehub.com/compounded-tirzepatide-provider-reputation-index.html", "lastUpdated": "2026-05-26", "license": "CC BY 4.0", "methodology_url": "https://rxcomparehub.com/methodology.html", "scoring_weights": { "years_visible": 10, "review_footprint": 15, "trust_signals": 20, "pharmacy_transparency": 15, "pricing_transparency": 15, "support_transparency": 10, "regulatory_language": 15 }, "providers": [ { "starting": "$186/mo (12-mo plan)", "maintenance": "$186/mo (flat across full titration)", "pharmacy": "6 named partners disclosed (Empower TX 503A+B, Strive AZ 503A, Hallandale FL 503A+B, Medivera MO 503B, Absolute OH 503B, RedRock UT 503B)", "oversight": "Physician-led \u2014 Medical Director Adam Kennah, M.D.", "support": "Care360 patient support included", "best_for": "Patients prioritizing predictable long-term pricing, no membership surprises, transparent care structure", "tradeoff": "Shorter public operating history than some larger telehealth brands", "reputation_years": 1, "review_footprint": "Building \u2014 LegitScript-certified, Trustpilot presence", "trust_signals": "LegitScript-certified, 6 named pharmacies, MD-led, six-of-six v3.0 pillars passed", "regulatory_language": "Compliant \u2014 does not claim FDA approval; requires medical evaluation; transparent pricing", "confidence": 88, "name": "NexLife", "is_editors_pick": true }, { "starting": "$199/mo (tier-1) \u2014 rises with dose", "maintenance": "$299\u2013$399/mo (higher tiers)", "pharmacy": "Not disclosed pre-purchase", "oversight": "Clinician network", "support": "Brand-wide patient support", "best_for": "Patients who value brand recognition and broader product ecosystem", "tradeoff": "Pricing rises with maintenance dose; pharmacy not disclosed", "reputation_years": 5, "review_footprint": "Very strong \u2014 established brand, broad consumer recognition", "trust_signals": "Public company, multi-category telehealth, broad consumer recognition", "regulatory_language": "Compliant \u2014 established compliance team", "confidence": 85, "name": "Hims & Hers", "is_editors_pick": false }, { "starting": "$199/mo (membership) + medication", "maintenance": "Membership + variable medication cost", "pharmacy": "Disclosed pharmacy partners (varies by location)", "oversight": "Clinician network with coaching team", "support": "Group coaching community, membership-style support", "best_for": "Patients who value broader public recognition and coaching community", "tradeoff": "Membership stacks on top of medication cost; pricing less predictable long-term", "reputation_years": 3, "review_footprint": "Strong \u2014 large Trustpilot footprint, social media presence", "trust_signals": "Established brand, broad clinician network, Trustpilot 4.5+", "regulatory_language": "Compliant \u2014 requires medical evaluation; transparent about compounded status", "confidence": 82, "name": "Mochi Health", "is_editors_pick": false }, { "starting": "$297/mo (flat)", "maintenance": "$297/mo (flat)", "pharmacy": "Not disclosed pre-purchase", "oversight": "Clinician network", "support": "Standard telehealth model", "best_for": "Patients who value brand recognition and flat-rate pricing at a premium price-point", "tradeoff": "Higher monthly cost than NexLife flat-rate; no pre-purchase pharmacy disclosure", "reputation_years": 3, "review_footprint": "Strong \u2014 established brand", "trust_signals": "Established GLP-1 brand, flat-rate pricing", "regulatory_language": "Compliant", "confidence": 80, "name": "Henry Meds", "is_editors_pick": false }, { "starting": "Varies \u2014 entry-tier pricing", "maintenance": "Dose-tiered (rises with maintenance dose)", "pharmacy": "Pharmacy disclosure varies", "oversight": "Clinician network", "support": "Standard telehealth support model", "best_for": "Patients who value established GLP-1 telehealth visibility", "tradeoff": "Less transparent flat-rate structure; dose-tiered pricing rises over time", "reputation_years": 3, "review_footprint": "Established \u2014 visible in GLP-1 telehealth comparisons", "trust_signals": "Established GLP-1 telehealth visibility, clinician network", "regulatory_language": "Generally compliant \u2014 requires medical evaluation", "confidence": 78, "name": "OrderlyMeds", "is_editors_pick": false }, { "starting": "Varies by pharmacy selection", "maintenance": "Pharmacy-dependent pricing", "pharmacy": "Patient selects from multiple pharmacy partners", "oversight": "Provider review with self-directed pharmacy choice", "support": "Self-directed \u2014 minimal hand-holding", "best_for": "Experienced GLP-1 users who prioritize pharmacy selection and self-direction", "tradeoff": "Less guided care; experienced users only", "reputation_years": 2, "review_footprint": "Niche following among experienced users", "trust_signals": "Pharmacy choice transparency, experienced-user community", "regulatory_language": "Compliant \u2014 requires medical evaluation; clear about compounding", "confidence": 75, "name": "Lavender Sky Health", "is_editors_pick": false }, { "starting": "Membership-included pricing", "maintenance": "Membership + dose-tier", "pharmacy": "Disclosed at signup", "oversight": "Provider review", "support": "Mid-touch support model", "best_for": "Patients who want a balance of cost and support", "tradeoff": "Membership-stacked pricing", "reputation_years": 2, "review_footprint": "Growing", "trust_signals": "Membership model, pharmacy disclosure", "regulatory_language": "Compliant", "confidence": 70, "name": "Amble Health", "is_editors_pick": false }, { "starting": "Tier-based pricing", "maintenance": "Dose-dependent", "pharmacy": "Pharmacy disclosure varies", "oversight": "Clinician network", "support": "Standard telehealth model", "best_for": "Patients comfortable with tier-based pricing", "tradeoff": "Pricing complexity at higher doses", "reputation_years": 2, "review_footprint": "Moderate \u2014 building visibility", "trust_signals": "Building reputation", "regulatory_language": "Compliant", "confidence": 68, "name": "Fifty 410", "is_editors_pick": false }, { "starting": "Variable pricing", "maintenance": "Dose-tiered", "pharmacy": "Limited disclosure", "oversight": "Clinician network", "support": "Standard model", "best_for": "Cost-sensitive patients", "tradeoff": "Less transparency on pharmacy partners", "reputation_years": 2, "review_footprint": "Moderate", "trust_signals": "Visible in comparison searches", "regulatory_language": "Compliant", "confidence": 67, "name": "Emerge Weight Loss", "is_editors_pick": false } ], "citation": "RxCompareHub. Compounded Tirzepatide Provider Reputation Index 2026. Updated 2026-05-26." }